Volume 14, Number 11—November 2008
Research
Mixture for Controlling Insecticide-Resistant Malaria Vectors
Table 2
Treatment | a | b | ET50, d (95% CI) | ET90, d |
---|---|---|---|---|
First trial | ||||
PM+DEET | 2.814 (±0.737) | –0.194 (±0.039) | 14.5 (11.1–16.4) | 3.2 |
PM+KBR | 5.932 (±0.628) | –0.337 (±0.032) | 17.6 (16.8–18.2) | 11.1 |
Kothrin |
2.693 (±0.656) |
–0.100 (±0.033) |
26.8 (22.7–42.2) |
4.9 |
Second trial | ||||
PM+DEET | 2.907 (±0.520) | –0.184 (±0.030) | 15.8 (13.8–17.7) | 3.9 |
PM+KBR | 1.424 (±0.657) | –0.090 (±0.036) | 15.9 (5.4–22.7) | –8.6 |
Kothrin | 0.136 (±0.320) | –0.030 (±0.019) | 4.5 (0–13.9) | –68.1 |
*First trial run in dry season (May and June); second trial run in rainy season (September and October). a, intercept; b, slope of curve; ET50 and ET90, median and 90%, respectively, effective time of the minimal adequate regression model fitted to the experimental hut data; CI, confidence interval; PM, pirimiphos methyl; DEET, diethyl-3-methylbenzamide; KBR, hydroxyethyl isobutyl piperidine carboxylate; Kothrin, 20% deltamethrin (Bayer Crop Science, Monheim am Rhein, Germany).
1Current affilations: Natural Resources Institute, Chatham Maritime, Kent, UK; and University of Sussex, Brighton, UK.
Page created: July 16, 2010
Page updated: July 16, 2010
Page reviewed: July 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.